Fundamental principles of an effective diabetic retinopathy screening program
Background Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR. Methods A working group of ophthalmic and diabetes experts was established to develop a consensus on the key princi...
Gespeichert in:
Veröffentlicht in: | Acta diabetologica 2020-07, Vol.57 (7), p.785-798 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 798 |
---|---|
container_issue | 7 |
container_start_page | 785 |
container_title | Acta diabetologica |
container_volume | 57 |
creator | Lanzetta, Paolo Sarao, Valentina Scanlon, Peter H. Barratt, Jane Porta, Massimo Bandello, Francesco Loewenstein, Anat |
description | Background
Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR.
Methods
A working group of ophthalmic and diabetes experts was established to develop a consensus on the key principles of an effective DR screening program. Recommendations are based on analysis of a structured literature review.
Results
The recommendations for implementing an effective DR screening program are: (1) Examination methods must be suitable for the screening region, and DR classification/grading systems must be systematic and uniformly applied. Two-field retinal imaging is sufficient for DR screening and is preferable to seven-field imaging, and referable DR should be well defined and reliably identifiable by qualified screening staff; (2) in many countries/regions, screening can and should take place outside the ophthalmology clinic; (3) screening staff should be accredited and show evidence of ongoing training; (4) screening programs should adhere to relevant national quality assurance standards; (5) studies that use uniform definitions of risk to determine optimum risk-based screening intervals are required; (6) technology infrastructure should be in place to ensure that high-quality images can be stored securely to protect patient information; (7) although screening for diabetic macular edema (DME) in conjunction with DR evaluations may have merit, there is currently insufficient evidence to support implementation of programs solely for DME screening.
Conclusion
Use of these recommendations may yield more effective DR screening programs that reduce the risk of vision loss worldwide. |
doi_str_mv | 10.1007/s00592-020-01506-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7311555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2384493820</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-6e1ce0b995ece743f47d3232986ffea1f6714eeb5588ac063eb36d625dcbde993</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhS0EopfCC7BAkdiwCYw9dmJvkFBFAamIDawtx5ncukrsi51U6tvjckv5WeCFvfB3zpzRYew5h9ccoH9TAJQRLQhogSvoWv2A7bhE0SqB-JDtwEholRTmhD0p5QqAix71Y3aCoh7N9Y59Pt_i6BaKq5ubQw7Rh8NMpUlT42JD00R-DdfUjMENtAbf5HrHdHDr5U1TfCaKIe6rMu2zW56yR5ObCz27e0_Zt_P3X88-thdfPnw6e3fRetnLte2Ie4LBGEWeeomT7EcUKIzu6kDHp67nkmhQSmvnoUMasBs7oUY_jGQMnrK3R9_DNiw0-ho_u9nW_IvLNza5YP_-ieHS7tO17ZFzpVQ1eHVnkNP3jcpql1A8zbOLlLZiBWopDWoBFX35D3qVthzrelZI3iHXBnmlxJHyOZWSaboPw8HetmWPbdnalv3ZltVV9OLPNe4lv-qpAB6BclvNnvLv2f-x_QH2-KGd</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2416318931</pqid></control><display><type>article</type><title>Fundamental principles of an effective diabetic retinopathy screening program</title><source>MEDLINE</source><source>SpringerLink (Online service)</source><creator>Lanzetta, Paolo ; Sarao, Valentina ; Scanlon, Peter H. ; Barratt, Jane ; Porta, Massimo ; Bandello, Francesco ; Loewenstein, Anat</creator><creatorcontrib>Lanzetta, Paolo ; Sarao, Valentina ; Scanlon, Peter H. ; Barratt, Jane ; Porta, Massimo ; Bandello, Francesco ; Loewenstein, Anat ; Vision Academy ; the Vision Academy</creatorcontrib><description>Background
Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR.
Methods
A working group of ophthalmic and diabetes experts was established to develop a consensus on the key principles of an effective DR screening program. Recommendations are based on analysis of a structured literature review.
Results
The recommendations for implementing an effective DR screening program are: (1) Examination methods must be suitable for the screening region, and DR classification/grading systems must be systematic and uniformly applied. Two-field retinal imaging is sufficient for DR screening and is preferable to seven-field imaging, and referable DR should be well defined and reliably identifiable by qualified screening staff; (2) in many countries/regions, screening can and should take place outside the ophthalmology clinic; (3) screening staff should be accredited and show evidence of ongoing training; (4) screening programs should adhere to relevant national quality assurance standards; (5) studies that use uniform definitions of risk to determine optimum risk-based screening intervals are required; (6) technology infrastructure should be in place to ensure that high-quality images can be stored securely to protect patient information; (7) although screening for diabetic macular edema (DME) in conjunction with DR evaluations may have merit, there is currently insufficient evidence to support implementation of programs solely for DME screening.
Conclusion
Use of these recommendations may yield more effective DR screening programs that reduce the risk of vision loss worldwide.</description><identifier>ISSN: 0940-5429</identifier><identifier>ISSN: 1432-5233</identifier><identifier>EISSN: 1432-5233</identifier><identifier>DOI: 10.1007/s00592-020-01506-8</identifier><identifier>PMID: 32222818</identifier><language>eng</language><publisher>Milan: Springer Milan</publisher><subject>Adult ; Blindness ; Consensus ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus - diagnosis ; Diabetes Mellitus - pathology ; Diabetic retinopathy ; Diabetic Retinopathy - diagnosis ; Edema ; Eye Complications of Diabetes ; Female ; Humans ; Internal Medicine ; Literature reviews ; Macular Edema - diagnosis ; Male ; Mass Screening - methods ; Mass Screening - organization & administration ; Mass Screening - standards ; Medicine ; Medicine & Public Health ; Metabolic Diseases ; Middle Aged ; Position Statement ; Practice Guidelines as Topic ; Program Evaluation - methods ; Program Evaluation - standards ; Quality assurance ; Referral and Consultation - organization & administration ; Referral and Consultation - standards ; Retinopathy ; Telemedicine ; Vision</subject><ispartof>Acta diabetologica, 2020-07, Vol.57 (7), p.785-798</ispartof><rights>The Author(s) 2020. corrected publication 2020</rights><rights>The Author(s) 2020. corrected publication 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020, corrected publication 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-6e1ce0b995ece743f47d3232986ffea1f6714eeb5588ac063eb36d625dcbde993</citedby><cites>FETCH-LOGICAL-c474t-6e1ce0b995ece743f47d3232986ffea1f6714eeb5588ac063eb36d625dcbde993</cites><orcidid>0000-0003-3746-141X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00592-020-01506-8$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00592-020-01506-8$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32222818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lanzetta, Paolo</creatorcontrib><creatorcontrib>Sarao, Valentina</creatorcontrib><creatorcontrib>Scanlon, Peter H.</creatorcontrib><creatorcontrib>Barratt, Jane</creatorcontrib><creatorcontrib>Porta, Massimo</creatorcontrib><creatorcontrib>Bandello, Francesco</creatorcontrib><creatorcontrib>Loewenstein, Anat</creatorcontrib><creatorcontrib>Vision Academy</creatorcontrib><creatorcontrib>the Vision Academy</creatorcontrib><title>Fundamental principles of an effective diabetic retinopathy screening program</title><title>Acta diabetologica</title><addtitle>Acta Diabetol</addtitle><addtitle>Acta Diabetol</addtitle><description>Background
Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR.
Methods
A working group of ophthalmic and diabetes experts was established to develop a consensus on the key principles of an effective DR screening program. Recommendations are based on analysis of a structured literature review.
Results
The recommendations for implementing an effective DR screening program are: (1) Examination methods must be suitable for the screening region, and DR classification/grading systems must be systematic and uniformly applied. Two-field retinal imaging is sufficient for DR screening and is preferable to seven-field imaging, and referable DR should be well defined and reliably identifiable by qualified screening staff; (2) in many countries/regions, screening can and should take place outside the ophthalmology clinic; (3) screening staff should be accredited and show evidence of ongoing training; (4) screening programs should adhere to relevant national quality assurance standards; (5) studies that use uniform definitions of risk to determine optimum risk-based screening intervals are required; (6) technology infrastructure should be in place to ensure that high-quality images can be stored securely to protect patient information; (7) although screening for diabetic macular edema (DME) in conjunction with DR evaluations may have merit, there is currently insufficient evidence to support implementation of programs solely for DME screening.
Conclusion
Use of these recommendations may yield more effective DR screening programs that reduce the risk of vision loss worldwide.</description><subject>Adult</subject><subject>Blindness</subject><subject>Consensus</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus - diagnosis</subject><subject>Diabetes Mellitus - pathology</subject><subject>Diabetic retinopathy</subject><subject>Diabetic Retinopathy - diagnosis</subject><subject>Edema</subject><subject>Eye Complications of Diabetes</subject><subject>Female</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Literature reviews</subject><subject>Macular Edema - diagnosis</subject><subject>Male</subject><subject>Mass Screening - methods</subject><subject>Mass Screening - organization & administration</subject><subject>Mass Screening - standards</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic Diseases</subject><subject>Middle Aged</subject><subject>Position Statement</subject><subject>Practice Guidelines as Topic</subject><subject>Program Evaluation - methods</subject><subject>Program Evaluation - standards</subject><subject>Quality assurance</subject><subject>Referral and Consultation - organization & administration</subject><subject>Referral and Consultation - standards</subject><subject>Retinopathy</subject><subject>Telemedicine</subject><subject>Vision</subject><issn>0940-5429</issn><issn>1432-5233</issn><issn>1432-5233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9kc1u1TAQhS0EopfCC7BAkdiwCYw9dmJvkFBFAamIDawtx5ncukrsi51U6tvjckv5WeCFvfB3zpzRYew5h9ccoH9TAJQRLQhogSvoWv2A7bhE0SqB-JDtwEholRTmhD0p5QqAix71Y3aCoh7N9Y59Pt_i6BaKq5ubQw7Rh8NMpUlT42JD00R-DdfUjMENtAbf5HrHdHDr5U1TfCaKIe6rMu2zW56yR5ObCz27e0_Zt_P3X88-thdfPnw6e3fRetnLte2Ie4LBGEWeeomT7EcUKIzu6kDHp67nkmhQSmvnoUMasBs7oUY_jGQMnrK3R9_DNiw0-ho_u9nW_IvLNza5YP_-ieHS7tO17ZFzpVQ1eHVnkNP3jcpql1A8zbOLlLZiBWopDWoBFX35D3qVthzrelZI3iHXBnmlxJHyOZWSaboPw8HetmWPbdnalv3ZltVV9OLPNe4lv-qpAB6BclvNnvLv2f-x_QH2-KGd</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Lanzetta, Paolo</creator><creator>Sarao, Valentina</creator><creator>Scanlon, Peter H.</creator><creator>Barratt, Jane</creator><creator>Porta, Massimo</creator><creator>Bandello, Francesco</creator><creator>Loewenstein, Anat</creator><general>Springer Milan</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3746-141X</orcidid></search><sort><creationdate>20200701</creationdate><title>Fundamental principles of an effective diabetic retinopathy screening program</title><author>Lanzetta, Paolo ; Sarao, Valentina ; Scanlon, Peter H. ; Barratt, Jane ; Porta, Massimo ; Bandello, Francesco ; Loewenstein, Anat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-6e1ce0b995ece743f47d3232986ffea1f6714eeb5588ac063eb36d625dcbde993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Blindness</topic><topic>Consensus</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus - diagnosis</topic><topic>Diabetes Mellitus - pathology</topic><topic>Diabetic retinopathy</topic><topic>Diabetic Retinopathy - diagnosis</topic><topic>Edema</topic><topic>Eye Complications of Diabetes</topic><topic>Female</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Literature reviews</topic><topic>Macular Edema - diagnosis</topic><topic>Male</topic><topic>Mass Screening - methods</topic><topic>Mass Screening - organization & administration</topic><topic>Mass Screening - standards</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic Diseases</topic><topic>Middle Aged</topic><topic>Position Statement</topic><topic>Practice Guidelines as Topic</topic><topic>Program Evaluation - methods</topic><topic>Program Evaluation - standards</topic><topic>Quality assurance</topic><topic>Referral and Consultation - organization & administration</topic><topic>Referral and Consultation - standards</topic><topic>Retinopathy</topic><topic>Telemedicine</topic><topic>Vision</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lanzetta, Paolo</creatorcontrib><creatorcontrib>Sarao, Valentina</creatorcontrib><creatorcontrib>Scanlon, Peter H.</creatorcontrib><creatorcontrib>Barratt, Jane</creatorcontrib><creatorcontrib>Porta, Massimo</creatorcontrib><creatorcontrib>Bandello, Francesco</creatorcontrib><creatorcontrib>Loewenstein, Anat</creatorcontrib><creatorcontrib>Vision Academy</creatorcontrib><creatorcontrib>the Vision Academy</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta diabetologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lanzetta, Paolo</au><au>Sarao, Valentina</au><au>Scanlon, Peter H.</au><au>Barratt, Jane</au><au>Porta, Massimo</au><au>Bandello, Francesco</au><au>Loewenstein, Anat</au><aucorp>Vision Academy</aucorp><aucorp>the Vision Academy</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fundamental principles of an effective diabetic retinopathy screening program</atitle><jtitle>Acta diabetologica</jtitle><stitle>Acta Diabetol</stitle><addtitle>Acta Diabetol</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>57</volume><issue>7</issue><spage>785</spage><epage>798</epage><pages>785-798</pages><issn>0940-5429</issn><issn>1432-5233</issn><eissn>1432-5233</eissn><abstract>Background
Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR.
Methods
A working group of ophthalmic and diabetes experts was established to develop a consensus on the key principles of an effective DR screening program. Recommendations are based on analysis of a structured literature review.
Results
The recommendations for implementing an effective DR screening program are: (1) Examination methods must be suitable for the screening region, and DR classification/grading systems must be systematic and uniformly applied. Two-field retinal imaging is sufficient for DR screening and is preferable to seven-field imaging, and referable DR should be well defined and reliably identifiable by qualified screening staff; (2) in many countries/regions, screening can and should take place outside the ophthalmology clinic; (3) screening staff should be accredited and show evidence of ongoing training; (4) screening programs should adhere to relevant national quality assurance standards; (5) studies that use uniform definitions of risk to determine optimum risk-based screening intervals are required; (6) technology infrastructure should be in place to ensure that high-quality images can be stored securely to protect patient information; (7) although screening for diabetic macular edema (DME) in conjunction with DR evaluations may have merit, there is currently insufficient evidence to support implementation of programs solely for DME screening.
Conclusion
Use of these recommendations may yield more effective DR screening programs that reduce the risk of vision loss worldwide.</abstract><cop>Milan</cop><pub>Springer Milan</pub><pmid>32222818</pmid><doi>10.1007/s00592-020-01506-8</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-3746-141X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0940-5429 |
ispartof | Acta diabetologica, 2020-07, Vol.57 (7), p.785-798 |
issn | 0940-5429 1432-5233 1432-5233 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7311555 |
source | MEDLINE; SpringerLink (Online service) |
subjects | Adult Blindness Consensus Diabetes Diabetes mellitus Diabetes Mellitus - diagnosis Diabetes Mellitus - pathology Diabetic retinopathy Diabetic Retinopathy - diagnosis Edema Eye Complications of Diabetes Female Humans Internal Medicine Literature reviews Macular Edema - diagnosis Male Mass Screening - methods Mass Screening - organization & administration Mass Screening - standards Medicine Medicine & Public Health Metabolic Diseases Middle Aged Position Statement Practice Guidelines as Topic Program Evaluation - methods Program Evaluation - standards Quality assurance Referral and Consultation - organization & administration Referral and Consultation - standards Retinopathy Telemedicine Vision |
title | Fundamental principles of an effective diabetic retinopathy screening program |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T17%3A38%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fundamental%20principles%20of%20an%20effective%20diabetic%20retinopathy%20screening%20program&rft.jtitle=Acta%20diabetologica&rft.au=Lanzetta,%20Paolo&rft.aucorp=Vision%20Academy&rft.date=2020-07-01&rft.volume=57&rft.issue=7&rft.spage=785&rft.epage=798&rft.pages=785-798&rft.issn=0940-5429&rft.eissn=1432-5233&rft_id=info:doi/10.1007/s00592-020-01506-8&rft_dat=%3Cproquest_pubme%3E2384493820%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2416318931&rft_id=info:pmid/32222818&rfr_iscdi=true |